Driehaus Capital Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Driehaus Capital Management’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-12,242	Closed	-$57K	–	690
2017 Q1	$57K	Sell	12,242 -324,085	-96%	-$1.88M	﹤0.01%	528
2016 Q4	$2.05M	Sell	336,327 -217,826	-39%	-$1.14M	0.07%	253
2016 Q3	$3.05M	Buy	554,153 +500,182	+927%	+$2.34M	0.1%	204
2016 Q2	$205K	Buy	+53,971	New	+$183K	0.01%	507
2016 Q1	–	Sell	-489,127	Closed	-$2.77M	–	681
2015 Q4	$2.77M	Sell	489,127 -107,388	-18%	-$655K	0.09%	239
2015 Q3	$3.16M	Buy	596,515 +47,793	+9%	+$370K	0.11%	197
2015 Q2	$4.55M	Buy	+548,722	New	+$2.66M	0.16%	160
2013 Q3	–	Sell	-246,485	Closed	-$1.05M	–	543
2013 Q2	$1.05M	Buy	+246,485	New	+$1.24M	0.05%	342

Other funds holding SGYP

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Driehaus Capital Management's SGYP Position: Q2 2017 in Review

Driehaus Capital Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2017, closing a stake of 12,242 shares — an estimated $57K sold.

Driehaus Capital Management first reported a position in SGYP in Q2 2013 and held it in 8 quarters. The position peaked at $4.55M in Q2 2015. 146 funds tracked by Wall St. Rank hold SGYP as of Q2 2017.

Driehaus Capital Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2017 after selling out during the quarter.
Driehaus Capital Management sold 12,242 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2017, an estimated $57K.
Driehaus Capital Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 8 quarters.
Driehaus Capital Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $4.55M in Q2 2015.
146 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2017.

Based on Driehaus Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.